CWIG
DYN icon

Chung Wu Investment Group’s Dyne Therapeutics DYN Stock Holding History

Chung Wu Investment Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.3K Sell
2,000
-800
-29% -$13.8K 0.03% 146
2025
Q4 		$54.8K Buy
2,800
+400
+17% +$7.58K 0.04% 130
2025
Q3 		$30.4K Buy
+2,400
New +$27.4K 0.03% 157

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Chung Wu Investment Group's DYN Position: Q1 2026 in Review

Chung Wu Investment Group reduced its Dyne Therapeutics (DYN) stake by 29% in Q1 2026, selling an estimated $13.8K and leaving 2,000 shares worth $36.3K. The position accounts for 0.03% of the portfolio, ranked #146.

Chung Wu Investment Group first reported a position in DYN in Q3 2025 and has held it in 3 quarters since. The position peaked at $54.8K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Chung Wu Investment Group held 2,000 shares of Dyne Therapeutics worth $36.3K as of Q1 2026.
  • Chung Wu Investment Group sold 800 Dyne Therapeutics shares in Q1 2026, an estimated $13.8K.
  • Dyne Therapeutics made up 0.03% of Chung Wu Investment Group's portfolio in Q1 2026, its #146 holding.
  • Chung Wu Investment Group first reported a position in Dyne Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Chung Wu Investment Group's Dyne Therapeutics position peaked at $54.8K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Chung Wu Investment Group's 13F filing for Q1 2026, filed 12 May 2026.